首页> 外文期刊>Oncology Research >miR-641 Functions as a Tumor Suppressor by Targeting MDM2 in Human Lung Cancer
【24h】

miR-641 Functions as a Tumor Suppressor by Targeting MDM2 in Human Lung Cancer

机译:miR-641通过靶向人肺癌中的MDM2作为肿瘤抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Lung cancer is the leading cause of deaths due to cancer. Studies suggest an important role of microRNAs (miRNAs) in a variety of cancers, including lung cancer. In the present study, we evaluated the role of miR641 in human lung cancer A549 cells. Quantitative RT-PCR and Western blot were used to measure mRNA and protein expression, respectively. Cell viability and cell apoptosis were respectively measured by MTT assay and flow cytometry. In addition, luciferase activity assay was used to identify the target of miR-641. The expression of miR-641 was downregulated in lung cancer tissues and lung cancer cell lines (p 0.05 or p 0.01). Overexpression of miR-641 significantly inhibited proliferation and induced apoptosis of lung cancer cells (p 0.05, p 0.01, or p 0.001). MDM2 was identified as a direct target of miR-641. Overexpression of miR-641 decreased the expression of MDM2 and increased the expression of p53 in lung cancer cells.
机译:肺癌是癌症因死亡的主要原因。 研究表明MicroRNAS(miRNA)在各种癌症中的重要作用,包括肺癌。 在本研究中,我们评估了MiR641在人肺癌A549细胞中的作用。 定量RT-PCR和Western印迹分别用于测量mRNA和蛋白质表达。 通过MTT测定和流式细胞术分别测量细胞活力和细胞凋亡。 此外,荧光素酶活性测定用于鉴定miR-641的靶标。 miR-641的表达在肺癌组织和肺癌细胞系中下调(P <0.05或P <0.01)。 miR-641的过度表达显着抑制肺癌细胞的增殖和诱导凋亡(P <0.05,P <0.01或P <0.001)。 MDM2被识别为miR-641的直接目标。 miR-641的过表达降低了MDM2的表达,并增加了肺癌细胞中p53的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号